Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-05-21 17:16:32 ET · period of report 2026-05-19 · accession 0001193125-26-234891 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 17:16 | 2026-05-19 | PHAT | Parikh Asit | Dir | A - Grant | $0.00 | +24.1K | 34.6K | +230% | $0 |
| D | 2026-05-21 17:16 | 2026-05-20 | PHAT | Parikh Asit | Dir | M - OptEx | $4.95 | +17.5K | 52.1K | +51% | +$86.6K |
| D | 2026-05-21 17:16 | 2026-05-20 | PHAT | Parikh Asit | Dir | D - Sale to Iss | $0.00 | -17.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | A | A | 24,122 | $0.00 | 34,622 | D | — | — | (F1) The Restricted Stock Units ("RSUs") were granted on May 19, 2026, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. |
| 2 | Common | Common Stock | 2026-05-20 | M | A | 17,500 | $4.95 | 52,122 | D | — | — | |
| 3 | Derivative | Common Stock (Right to Buy) | 2026-05-20 | D | D | 17,500 | $0.00 | 0 | D | $4.95 · 2026-05-19 to 2035-06-02 | 17,500 Common Stock |